Why Did SoundHound AI Stock Go Up?
SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…
Buy
62
TCNNF Quote, Financials, Valuation and Earnings
Last price:
$8.10
Seasonality move
:
0.19%
Day range:
$8.00 - $8.37
52-week range:
$3.02 - $11.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.30x
P/B ratio:
1.29x
Volume:
142.7K
Avg. volume:
850.8K
1-year change:
68.05%
Market cap:
$1.5B
Revenue:
$1.2B
EPS (TTM):
-$0.70
Analysts' Opinion
-
Consensus RatingTrulieve Cannabis Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $21.00, Trulieve Cannabis Corp. has an estimated upside of 159.26% from its current price of $8.10.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $21.00 representing 100% downside risk from its current price of $8.10.
Fair Value
-
According to the consensus of 8 analysts, Trulieve Cannabis Corp. has 159.26% upside to fair value with a price target of $21.00 per share.
TCNNF vs. S&P 500
-
Over the past 5 trading days, Trulieve Cannabis Corp. has underperformed the S&P 500 by -8.84% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Trulieve Cannabis Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Trulieve Cannabis Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Trulieve Cannabis Corp. reported revenues of $288.2M.
Earnings Growth
-
Trulieve Cannabis Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Trulieve Cannabis Corp. reported earnings per share of -$0.14.
Enterprise value:
1.9B
EV / Invested capital:
--
Price / LTM sales:
1.30x
EV / EBIT:
14.51x
EV / Revenue:
1.59x
PEG ratio (5yr expected):
-0.13x
EV / Free cash flow:
13.32x
Price / Operating cash flow:
10.88x
Enterprise value / EBITDA:
6.20x
Gross Profit (TTM):
$606.2M
Return On Assets:
-4.54%
Net Income Margin (TTM):
-11.12%
Return On Equity:
-10.71%
Return On Invested Capital:
-6.43%
Operating Margin:
15.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.2B | $1.2B | $284.3M | $288.2M | |
| Gross Profit | $479.5M | $571.3M | $606.2M | $144.9M | $140.4M | |
| Operating Income | $66.9M | $121.9M | $130.5M | -$4.2M | $45.2M | |
| EBITDA | $242.8M | $293.7M | $305.5M | $40.4M | $88.6M | |
| Diluted EPS | -$3.02 | -$0.75 | -$0.70 | -$0.33 | -$0.14 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $385.7M | $492.6M | $486.7M | $603M | $756.4M | |
| Total Assets | $1.3B | $3.3B | $2.8B | $2.9B | $2.9B | |
| Current Liabilities | $94.5M | $150.3M | $251.8M | $136.7M | $124.1M | |
| Total Liabilities | $453.4M | $1.3B | $1.3B | $1.6B | $1.8B | |
| Total Equity | $822.6M | $2B | $1.4B | $1.3B | $1.2B | |
| Total Debt | $335.7M | $930.8M | $893.2M | $809.1M | $800.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $124.2M | $371.6M | $242.9M | $30.2M | $77.5M | |
| Cash From Investing | -$60.8M | -$187M | -$46.8K | -$128M | -$15.7M | |
| Cash From Financing | $19.3M | -$144M | -$21.1M | -$19.3M | -$4.8M | |
| Free Cash Flow | $50.2M | $254.7M | $142.2M | -$19.8M | $60.8M | |
TCNNF
Sector
Market Cap
$1.5B
$26M
Price % of 52-Week High
68.47%
51.81%
Dividend Yield
0%
0%
Shareholder Yield
-0.17%
-1.66%
1-Year Price Total Return
68.05%
-18.29%
Beta (5-Year)
1.082
0.485
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
-0.01%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$8.54
200-day SMA
Buy
Level
$6.11
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$8.39
Relative Strength Index (RSI14)
Sell
Level
49.14
ADX Line
Neutral
Level
0
Williams %R
Buy
Level
-81.6761
50-day SMA
Buy
Level
$7.34
MACD (12, 26)
Buy
Level
0.19
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.6647)
Sell
CA Score
(Annual)
Level (-0.3101)
Buy
Beneish M-Score
(Annual)
Level (-3.3274)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.2944)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.
Stock Forecast FAQ
In the current month, TCNNF has received 8 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TCNNF average analyst price target in the past 3 months is $21.00.
-
Where Will Trulieve Cannabis Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Trulieve Cannabis Corp. share price will rise to $21.00 per share over the next 12 months.
-
What Do Analysts Say About Trulieve Cannabis Corp.?
Analysts are divided on their view about Trulieve Cannabis Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Trulieve Cannabis Corp. is a Sell and believe this share price will drop from its current level to $21.00.
-
What Is Trulieve Cannabis Corp.'s Price Target?
The price target for Trulieve Cannabis Corp. over the next 1-year time period is forecast to be $21.00 according to 8 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TCNNF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Trulieve Cannabis Corp. is a Buy. 8 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TCNNF?
You can purchase shares of Trulieve Cannabis Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Trulieve Cannabis Corp. shares.
-
What Is The Trulieve Cannabis Corp. Share Price Today?
Trulieve Cannabis Corp. was last trading at $8.10 per share. This represents the most recent stock quote for Trulieve Cannabis Corp.. Yesterday, Trulieve Cannabis Corp. closed at $8.10 per share.
-
How To Buy Trulieve Cannabis Corp. Stock Online?
In order to purchase Trulieve Cannabis Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get TCNNF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TCNNF
Sector
P/E ratio
--
23.85x
PEG ratio
-0.13x
-0.01x
P/B ratio
1.29x
1.83x
Price / LTM sales
1.30x
1.56x
Growth Metrics
TCNNF
Sector
Revenue growth
1.37%
4.18%
Earnings growth
57.15%
9.66%
Revenue (5-year growth)
36.24%
6.28%
Earnings forecast
-$0.03
-$0.18
Profitability
TCNNF
Sector
Profitability FY 2024
$602.9M
$3.1M
Return on invested capital
-6.43%
-32.89%
Return on assets
-4.54%
-29.56%
Return on equity
-10.71%
-38.66%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
4
Balance Sheet
TCNNF
Sector
Total cash
$450.1M
$25.2M
Short term investments
$60.4M
$25.1M
Total assets
$2.9B
$73M
Long term debt
$800.3M
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Goldman Sachs Going to Go Up?
Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…
How High Will MSTR Stock Go?
After several months of pressure, shares of Bitcoin treasury Strategy…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
59
RGC alert for Jan 23
Regencell Bioscience Holdings Ltd. [RGC] is up 4% over the past day.
Buy
76
HYMC alert for Jan 23
Hycroft Mining Holding Corp. [HYMC] is up 8.29% over the past day.
Sell
24
INSP alert for Jan 23
Inspire Medical Systems, Inc. [INSP] is down 0.89% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
